COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,575 Articles (22,415 medRxiv, 8,160 bioRxiv)

Most recent first Previous |  Page 2143: Articles 21421-21430  | Next

Performance characteristics of the VIDAS(R) SARS-COV-2 IgM and IgG serological assays
RENARD, N., DANIEL, S., CAYET, N., PECQUET, M., RAYMOND, F., PONS, S., LUPO, J., TOURNEUR, C., PRETIS, C., GEREZ, G., BLASCO, P., COMBE, M., CANOVA, I., LESENECHAL, M., BERTHIER, F.
10.1101/2020.09.28.20196030 — Posted: 2020-09-29
Impact of COVID-19 on Hospital Admission of Acute Stroke patients in Bangladesh
Hasan, A. T. M. H., Das, S. C., Islam, M. S., Mansur, M., Shawon, M. S. R., Hassan, R., Chowdhury, M. S. J. H., Mondal, M. B. A., Mohammad, Q. D.
10.1101/2020.09.28.316448 — Posted: 2020-09-28
Hydroxychloroquine increased psychiatric-like behaviors and disrupted the expression of related genes in the mouse brain
Xu, H., Zhang, X., Wang, W., Wang, J.
10.1101/2020.09.27.316158 — Posted: 2020-09-28 Discussion: Offsite
Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2
Ghorbani, M., Brooks, B. R., Klauda, J. B.
10.1101/2020.09.28.317206 — Posted: 2020-09-28
Fluorescence-detection size-exclusion chromatography utilizing nanobody technology for expression screening of membrane proteins
Jin, F., Wang, Y., Wang, M., Sun, M., Hattori, M.
10.1101/2020.09.28.316307 — Posted: 2020-09-28 Discussion: Onsite
Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes
Jain, R., Ramaswamy, S., Harilal, D., Uddin, M., Loney, T., Nowotny, N., Alsuwaidi, H., Varghese, R., Deesi, Z., Alkhajeh, A., Khansaheb, H., Alsheikh-Ali, A., Abou Tayoun, A.
10.1101/2020.09.28.316604 — Posted: 2020-09-28
Discovery and Development of Human SARS-CoV-2 Neutralizing Antibodies using an Unbiased Phage Display Library Approach
Cao, X., Maruyama, J., Zhou, H., Kerwin, L., Sattler, R., Manning, J. T., Johnson, S., Richards, S., Blair, B., Du, N., Morais, K., Lawrence, K., Lu, L., Pai, C.-I., Li, D., Brunswick, M., Zhang, Y., Ji, H., Paessler, S., Allen, R. D.
10.1101/2020.09.27.316174 — Posted: 2020-09-28
A Tethered Ligand Assay to Probe the SARS-CoV-2 ACE2 Interaction under Constant Force
Bauer, M. S., Gruber, S., Milles, L. F., Nicolaus, T., Schendel, L. C., Gaub, H. E., Lipfert, J.
10.1101/2020.09.27.315796 — Posted: 2020-09-28
Ultrafast Sample Placement on Existing Trees (UShER) Empowers Real-Time Phylogenetics for the SARS-CoV-2 Pandemic
Turakhia, Y., Thornlow, B., Hinrichs, A. S., de Maio, N., Gozashti, L., Lanfear, R., Haussler, D., Corbett-Detig, R.
10.1101/2020.09.26.314971 — Posted: 2020-09-28
No evidence that plasmablasts transdifferentiate into developing neutrophils in severe COVID-19 disease
Alquicira-Hernandez, J., Powell, J., Phan, T. G.
10.1101/2020.09.27.312538 — Posted: 2020-09-28 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).